Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Advanced Technologies for Novel Therapeutics
About
ATNT is a biotechnology company .
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $150K
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2008
- Operating Status
- Active
TNT founders are well-recognized university professors whose areas of expertise encompass molecular biology, cell biology, biochemistry, molecular genetics, human genetics, animal models, systems biology and engineering disciplines. Their staff members are high profile experts in engineering and biology. In ATNT they have successfully developed novel tools and techniques, to identify the most important therapeutic targets in complex cellular networks. Using patented technologies, ATNT provides a unique service to pharmaceutical and biotech companies. Their service will provide a set of therapeutic targets that have the minimal chance of failure, therefore minimizes the time and cost of finding novel therapeutics.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 11, 2012 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
